These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 26328154)
1. Approaching the optimal transurethral resection of a bladder tumor. Jurewicz M; Soloway MS Turk J Urol; 2014 Jun; 40(2):73-7. PubMed ID: 26328154 [TBL] [Abstract][Full Text] [Related]
2. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study). Miyake M; Nishimura N; Inoue T; Suzuki S; Fujii T; Owari T; Hori S; Nakai Y; Toritsuka M; Nakagawa H; Tsukamoto S; Anai S; Torimoto K; Yoneda T; Tanaka N; Fujimoto K Trials; 2021 Feb; 22(1):136. PubMed ID: 33579327 [TBL] [Abstract][Full Text] [Related]
3. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. Richards KA; Smith ND; Steinberg GD J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761 [TBL] [Abstract][Full Text] [Related]
4. Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized Trial. Gallagher K; Bhatt N; Clement K; Zimmermann E; Khadhouri S; MacLennan S; Kulkarni M; Gaba F; Anbarasan T; Asif A; Light A; Ng A; Chan V; Nathan A; Cooper D; Aucott L; Marcq G; Teoh JY; Hensley P; Duncan E; Goulao B; O'Brien T; Nielsen M; Mariappan P; Kasivisvanathan V JMIR Res Protoc; 2023 Jun; 12():e42254. PubMed ID: 37318875 [TBL] [Abstract][Full Text] [Related]
5. Initial experience with surrounding en bloc transurethral resection of bladder tumor and simultaneous intravesical treating for non-muscle invasive bladder cancer. Teng L; Li C; Wang W; Li D BMC Urol; 2022 Nov; 22(1):189. PubMed ID: 36419012 [TBL] [Abstract][Full Text] [Related]
6. Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer. Lai LY; Tafuri SM; Ginier EC; Herrel LA; Dahm P; Maisch P; Lane GI Cochrane Database Syst Rev; 2022 Apr; 4(4):CD014887. PubMed ID: 35393644 [TBL] [Abstract][Full Text] [Related]
7. Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours. Mostafid H; Kamat AM; Daneshmand S; Palou J; Taylor JA; McKiernan J; Catto J; Babjuk M; Soloway M Eur Urol Oncol; 2021 Feb; 4(1):12-19. PubMed ID: 32684515 [TBL] [Abstract][Full Text] [Related]
8. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results. Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J; Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749 [TBL] [Abstract][Full Text] [Related]
9. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer. Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924 [TBL] [Abstract][Full Text] [Related]
10. Transurethral resection of bladder tumour (TURBT). Kim LHC; Patel MI Transl Androl Urol; 2020 Dec; 9(6):3056-3072. PubMed ID: 33457279 [TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer. O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153 [TBL] [Abstract][Full Text] [Related]
13. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme. Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D; Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321 [TBL] [Abstract][Full Text] [Related]
14. Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer. Vanneste M; van der Heij B; Christiaansen CE; Berendsen CL; Driessen EJM; Bruins HM World J Urol; 2023 Aug; 41(8):2173-2178. PubMed ID: 37328699 [TBL] [Abstract][Full Text] [Related]
15. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM; BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434 [TBL] [Abstract][Full Text] [Related]
16. The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer. Nishimura N; Miyake M; Miyamoto T; Tomizawa M; Shimizu T; Morizawa Y; Hori S; Gotoh D; Nakai Y; Torimoto K; Tanaka N; Fujimoto K Jpn J Clin Oncol; 2023 Mar; 53(4):343-348. PubMed ID: 36585780 [TBL] [Abstract][Full Text] [Related]
17. Quality Control Indicators for Transurethral Resection of Bladder Tumor: Results from an Embedded Belgian Multicenter Prospective Registry. Muilwijk T; Akand M; Raskin Y; Jorissen C; Vander Eeckt K; Van Bruwaene S; Van Cleynenbreugel B; Joniau S; Van Der Aa F Eur Urol Oncol; 2023 Aug; 6(4):422-430. PubMed ID: 36543720 [TBL] [Abstract][Full Text] [Related]
18. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526 [TBL] [Abstract][Full Text] [Related]
19. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience. Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376 [TBL] [Abstract][Full Text] [Related]
20. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]